211 related articles for article (PubMed ID: 25816351)
1. The differential expression of OCT4 isoforms in cervical carcinoma.
Li SW; Wu XL; Dong CL; Xie XY; Wu JF; Zhang X
PLoS One; 2015; 10(3):e0118033. PubMed ID: 25816351
[TBL] [Abstract][Full Text] [Related]
2. The novel function of OCT4B isoform-265 in genotoxic stress.
Gao Y; Wei J; Han J; Wang X; Su G; Zhao Y; Chen B; Xiao Z; Cao J; Dai J
Stem Cells; 2012 Apr; 30(4):665-72. PubMed ID: 22247013
[TBL] [Abstract][Full Text] [Related]
3. OCT4B modulates OCT4A expression as ceRNA in tumor cells.
Li D; Yang ZK; Bu JY; Xu CY; Sun H; Tang JB; Lin P; Cheng W; Huang N; Cui RJ; Yu XG; Zheng XL
Oncol Rep; 2015 May; 33(5):2622-30. PubMed ID: 25812694
[TBL] [Abstract][Full Text] [Related]
4. OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.
Choi SH; Kim JK; Jeon HY; Eun K; Kim H
Mol Cells; 2019 Feb; 42(2):135-142. PubMed ID: 30622231
[TBL] [Abstract][Full Text] [Related]
5. A novel variant of Oct3/4 gene in mouse embryonic stem cells.
Guo CL; Liu L; Jia YD; Zhao XY; Zhou Q; Wang L
Stem Cell Res; 2012 Sep; 9(2):69-76. PubMed ID: 22683460
[TBL] [Abstract][Full Text] [Related]
6. The Octamer-Binding Transcription Factor 4 (OCT4) Pseudogene, POU Domain Class 5 Transcription Factor 1B (POU5F1B), is Upregulated in Cervical Cancer and Down-Regulation Inhibits Cell Proliferation and Migration and Induces Apoptosis in Cervical Cancer Cell Lines.
Yu J; Zhang J; Zhou L; Li H; Deng ZQ; Meng B
Med Sci Monit; 2019 Feb; 25():1204-1213. PubMed ID: 30762028
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of OCT4A and SPP1C transcript variant co-expression in early-stage lung adenocarcinoma.
Koshimune S; Kosaka M; Mizuno N; Yamamoto H; Miyamoto T; Ebisui K; Toyooka S; Ohtsuka A
BMC Cancer; 2020 Jun; 20(1):521. PubMed ID: 32503462
[TBL] [Abstract][Full Text] [Related]
8. Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology.
Wang X; Dai J
Stem Cells; 2010 May; 28(5):885-93. PubMed ID: 20333750
[TBL] [Abstract][Full Text] [Related]
9. Prognostication of OCT4 isoform expression in prostate cancer.
de Resende MF; Chinen LT; Vieira S; Jampietro J; da Fonseca FP; Vassallo J; Campos LC; Guimarães GC; Soares FA; Rocha RM
Tumour Biol; 2013 Oct; 34(5):2665-73. PubMed ID: 23636800
[TBL] [Abstract][Full Text] [Related]
10. Characterization of novel alternative splicing variants of Oct4 gene expressed in mouse pluripotent stem cells.
Liu X; Yu T; Sun Y; Wang H
J Cell Physiol; 2018 Jul; 233(7):5468-5477. PubMed ID: 29266259
[TBL] [Abstract][Full Text] [Related]
11. OCT4B2, a novel alternative spliced variant of OCT4, is significantly upregulated under heat-stress condition and downregulated in differentiated cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Tumour Biol; 2017 Oct; 39(10):1010428317724280. PubMed ID: 29022482
[TBL] [Abstract][Full Text] [Related]
12. OCT4B mediates hypoxia-induced cancer dissemination.
Lin SC; Chung CH; Chung CH; Kuo MH; Hsieh CH; Chiu YF; Shieh YS; Chou YT; Wu CW
Oncogene; 2019 Feb; 38(7):1093-1105. PubMed ID: 30209362
[TBL] [Abstract][Full Text] [Related]
13. The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B.
Gao Y; Wang X; Han J; Xiao Z; Chen B; Su G; Dai J
J Genet Genomics; 2010 Jul; 37(7):461-5. PubMed ID: 20659710
[TBL] [Abstract][Full Text] [Related]
14. Novel variant of OCT4B4 is differentially expressed in human embryonic stem and embryonic carcinoma cells.
Poursani EM; Mehravar M; Soltani BM; Mowla SJ
Gene; 2017 Sep; 627():369-372. PubMed ID: 28633916
[TBL] [Abstract][Full Text] [Related]
15. Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response.
Wang X; Zhao Y; Xiao Z; Chen B; Wei Z; Wang B; Zhang J; Han J; Gao Y; Li L; Zhao H; Zhao W; Lin H; Dai J
Stem Cells; 2009 Jun; 27(6):1265-75. PubMed ID: 19489092
[TBL] [Abstract][Full Text] [Related]
16. Conclusive Evidence for OCT4 Transcription in Human Cancer Cell Lines: Possible Role of a Small OCT4-Positive Cancer Cell Population.
Miyamoto T; Mizuno N; Kosaka M; Fujitani Y; Ohno E; Ohtsuka A
Stem Cells; 2018 Sep; 36(9):1341-1354. PubMed ID: 29770522
[TBL] [Abstract][Full Text] [Related]
17. Atypical expression and distribution of embryonic stem cell marker, OCT4, in human lung adenocarcinoma.
Karoubi G; Cortes-Dericks L; Gugger M; Galetta D; Spaggiari L; Schmid RA
J Surg Oncol; 2010 Nov; 102(6):689-98. PubMed ID: 20721963
[TBL] [Abstract][Full Text] [Related]
18. OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway.
Wang YD; Cai N; Wu XL; Cao HZ; Xie LL; Zheng PS
Cell Death Dis; 2013 Aug; 4(8):e760. PubMed ID: 23928699
[TBL] [Abstract][Full Text] [Related]
19. OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.
Asadi MH; Khalifeh K; Mowla SJ
J Neurooncol; 2016 Dec; 130(3):455-463. PubMed ID: 27585657
[TBL] [Abstract][Full Text] [Related]
20. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
